SEC Form 4 · accession 0001437749-26-029545
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Liane Rae Teplitsky
Officer — Chief Operating Officer
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 7:38 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Aug 31, 2026 | P | 1,024 | $48.80 | A | 3,094 | D | |
| Common StockF2,F4 | Sep 1, 2026 | P | 1,001 | $49.95 | A | 4,095 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws.
- F2The purchase of fractional shares has been rounded down to the nearest whole number.
- F3Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $48.76 to $48.80 per share.
- F4Open market purchase transactions made on the same day at the same price through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred at the reported price.